1999
DOI: 10.1172/jci7605
|View full text |Cite
|
Sign up to set email alerts
|

Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

13
275
3

Year Published

2002
2002
2017
2017

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 326 publications
(295 citation statements)
references
References 49 publications
13
275
3
Order By: Relevance
“…These affects were not simply a function of cardiac overexpression of a transgene, because we have not seen these pathologies with any of the other cardiac-specific transgenes we have described (18,22,(33)(34)(35). Similar hypertrophy has been reported for cardiac selective deletion of GLUT4, which also reduced glycolysis (8).…”
Section: Discussionsupporting
confidence: 72%
See 1 more Smart Citation
“…These affects were not simply a function of cardiac overexpression of a transgene, because we have not seen these pathologies with any of the other cardiac-specific transgenes we have described (18,22,(33)(34)(35). Similar hypertrophy has been reported for cardiac selective deletion of GLUT4, which also reduced glycolysis (8).…”
Section: Discussionsupporting
confidence: 72%
“…Diabetics are prone to heart failure (5) and they suffer more damage following an infarction (6). It has been proposed that reduced cardiac glycolysis contributes to the heart failure and cardiac damage often suffered by diabetics (7,8).…”
mentioning
confidence: 99%
“…S6C). Furthermore, prior work by ourselves and others with this specific Cre mouse line has shown no evidence of heart failure (17,(32)(33)(34).…”
Section: Tln2 Deletion Does Not Produce Changes In the Dystrophin-glymentioning
confidence: 87%
“…Mice bearing the targeted Capn4 PZ allele containing loxP sites flanking essential coding exons were generated as described previously (28). Transgenic mice with cardiomyocyte-specific expression of Cre recombinase under the control of ␣-myosin heavy chain (␣-MHC) (TgCre) were generously provided by Dr. Dale E. Abel (University of Utah) (29). Mice with cardiomyocyte-specific disruption of Capn4 (Capn4-ko) were generated by crossing floxed Capn4 PZ mice with transgenic mice overexpressing Cre under the control of the ␣-MHC promoter as we recently described (30).…”
Section: Methodsmentioning
confidence: 99%